Tesetaxel

Tesetaxel Suppliers list
Company Name: NCE Biomedical Co.,Ltd.  
Tel: 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Email:
Company Name: Shanghai Yongye Biotechnology Co., Ltd.  
Tel: 86-021-61559134 15921386130
Email: 3423497944@qq.com
Company Name: LETOPHARM LIMITED  
Tel: +86-21-5821 5861
Email: sales@letopharm.com
Company Name: SPIRO PHARMA  
Tel:
Email: eric_feng1954@126.com
Company Name: Shanghai ChengShao Biological Technology Co., Ltd.  
Tel: 021-61847300 13341622919
Email: shcss01@163.com
Tesetaxel Basic information
Product Name:Tesetaxel
Synonyms:Tesetaxel;DJ 927;2-Pyridinepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-3-fluoro-α-hydroxy-, (2aS,2bR,3S,4S,6S,8aR,10S,11aS,11bR,13aR)-2a-(acetyloxy)-3-(benzoyloxy)-10-[(dimethylamino)methyl]-2a,2b,3,4,5,6,8a,11a,11b,12,13,13a-dodecahydro-4-hydroxy-7,11b,14,14-tetramethyl-4,8-methano-2H-oxeto[3'',2'':3',4...;(2aS,2bR,3S,4S,6S,8aR,10R,11aS,11bR,13aR)-2a-acetoxy-6-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-3-(3-fluoropyridin-2-yl)-2-hydroxypropanoyl)oxy)-10-((dimethylamino)methyl)-4-hydroxy-7,11b,14,14-tetramethyl-2a,2b,3,4,5,6,8a,11a,11b,12,13,13a-dodecahydro-2H-4,8-methanooxeto[3'',2'':3',4']benzo[1',2':3,4]cyclodeca[1,2-d][1,3]dioxol-3-yl benzoate
CAS:333754-36-2
MF:C46H60FN3O13
MW:881.99
EINECS:
Product Categories:
Mol File:333754-36-2.mol
Tesetaxel Structure
Tesetaxel Chemical Properties
Melting point 147-149 °C
Boiling point 880.5±65.0 °C(Predicted)
density 1.34±0.1 g/cm3(Predicted)
pka10.17±0.46(Predicted)
Safety Information
MSDS Information
Tesetaxel Usage And Synthesis
UsesTesetaxel is a orally active, semisynthetic microtubule inhibitor of the taxane class for the research of cancer, including colorectal and gastric cancer.
References[1] Shionoya M, Jimbo T, Kitagawa M, Soga T, Tohgo A. DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo. Cancer Sci. 2003;94(5):459-466. DOI:10.1111/j.1349-7006.2003.tb01465.x
[2] Saif MW, Sarantopoulos J, Patnaik A, Tolcher AW, Takimoto C, Beeram M. Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011;68(6):1565-1573. DOI:10.1007/s00280-011-1639-3
Tesetaxel Preparation Products And Raw materials
Tag:Tesetaxel(333754-36-2) Related Product Information
Albendazole Tirbanibulin MonoMethyl auristatin E Docetaxel Eribulin VcMMAE